These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023. Jeong YD; Park S; Lee S; Jang W; Park J; Lee K; Lee J; Kang J; Udeh R; Rahmati M; Yeo SG; Smith L; Lee H; Yon DK Sci Rep; 2024 Oct; 14(1):24561. PubMed ID: 39427003 [TBL] [Abstract][Full Text] [Related]
9. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU. Das S; Khan RK; Alam SM; Chowdhury NH; Das P Mymensingh Med J; 2018 Jul; 27(3):631-640. PubMed ID: 30141456 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series. Germano F; Bellucci M; Grisanti S; Beronio A; Grazzini M; Coco E; Tassinari T; Della Cava F; De Michelis C; Baldi O; Sivori G; Murialdo A; Cabona C; Durando P; Uccelli A; Schenone A; Franciotta D; Benedetti L J Neurol Sci; 2022 Sep; 440():120330. PubMed ID: 35802961 [TBL] [Abstract][Full Text] [Related]
11. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome. Hilts A; Schreiber A; Singh A Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825 [TBL] [Abstract][Full Text] [Related]
12. Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report. Hwang BW; Bong JB Medicine (Baltimore); 2022 Dec; 101(48):e32140. PubMed ID: 36482517 [TBL] [Abstract][Full Text] [Related]
13. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia. Sii HL; Ng SH; Wong VF; Law WC Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913 [TBL] [Abstract][Full Text] [Related]
14. Acute motor-sensory axonal polyneuropathy variant of Guillain-Barré syndrome with a thalamic lesion and COVID-19: a case report and discussion on mechanism. Geng N; Wang P; Zhang Y Front Neurol; 2023; 14():1227505. PubMed ID: 37780717 [TBL] [Abstract][Full Text] [Related]
15. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN. Tutar NK; Eyigürbüz T; Yildirim Z; Kale N Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408 [TBL] [Abstract][Full Text] [Related]
16. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child. Akçay N; Menentoğlu ME; Bektaş G; Şevketoğlu E J Med Virol; 2021 Sep; 93(9):5599-5602. PubMed ID: 33851741 [TBL] [Abstract][Full Text] [Related]
17. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature. Min YG; Ju W; Ha YE; Ban JJ; Lee SA; Sung JJ; Shin JY J Neuroimmunol; 2021 Oct; 359():577691. PubMed ID: 34416410 [TBL] [Abstract][Full Text] [Related]
18. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report. Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980 [TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal. Acharya B; Kc S; Karki S; Thapa P; Kc P Ann Med Surg (Lond); 2023 Mar; 85(3):466-469. PubMed ID: 36923770 [TBL] [Abstract][Full Text] [Related]
20. Guillan-Barré Syndrome after First Vaccination Dose against COVID-19: Case Report. Čenščák D; Ungermann L; Štětkářová I; Ehler E Acta Medica (Hradec Kralove); 2021; 64(3):183-186. PubMed ID: 34779385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]